- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in drugs
EU Recommends Suspending Hundreds Of Drugs Tested By Indian Firm Micro Therapeutic
Europe's medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to "unreliable" tests conducted by Indian contract research firm Micro Therapeutic Research Labs
Read More
US Bans Divi's Factory, Shares Hit 3-year Low
US health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the company's shares down to a near three-year low on Wednesday
Read More
Sun Pharma Says FDA To Lift Ban On Mohali Drug Plant
Sun Pharmaceutical Industries said on Tuesday that US regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years
Read More
Glenmark, Evestra To Jointly Develop And Sell NuvaRing Copy In US
Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market
Read More
Sun Pharma Q3 Profit Falls Nearly 5%; Below Estimates
Sun's net profit for the October-December period fell to Rs 1,472 crore from Rs 1,545 crore a year earlier
Read More
Lupin Q3 Profit Up 21%, Beats Estimate
Lupin Ltd reported a 21 per cent jump in its quarterly profit, beating analysts' estimates, helped by higher sales of its diabetes products in the United States
Read More
Pharma Industry Wants Budget To Offer Tax Clarity
The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development as part of its budget wish-list
Read More
US FDA Finds Quality Control Problems At Sun Pharma's Halol Plant
The US Food and Drug Administration has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows
Read More
Drugmaker Laurus Labs' Up To Rs 1,332 Crore IPO Fully Subscribed
Laurus Labs' initial public offering of shares to raise up to Rs 1,332 crore was fully subscribed on the last day of the sale on Thursday, stock exchange data showed.
Read More
Sun Pharma Says US Finds More Concerns At Halol Plant
Sun Pharmaceutical Industries said on Wednesday the US health regulator has informed the company of more concerns found at its Halol manufacturing plant after a recent inspection
Read More
Dr Reddy's Profit Misses View As Emerging Markets Sales Fall
Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, reported a quarterly profit that was below analysts' estimates due to a drop in sales, mainly in emerging markets
Read More
Biosimilar Market To Cross $40 Billion In India By 2030
With the introduction of a new regulatory policy in India and increased affordability that biosimilars offer, the domestic market is expected to grow at an accelerated pace
Read More
Cipla First Quarter Profit Lags Estimates; Names New CEO
The company reported a lower-than-expected quarterly profit as revenues in its home market were hit by government measures to cut drug prices
Read More
Sun Pharma First-quarter Profit Boosted By Gleevec Generic
Sun Pharmaceutical Industries reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States
Read More
Indian Pharma Market Regains Growth
Indian pharmaceutical market regained its growth momentum in July after a weak trajectory in the previous three to four months
Read More